Nigericin exerts anticancer effects through inhibition of the SRC/STAT3/BCL-2 in osteosarcoma.

Yang, Zhiqiang; Xie, Jiangtao; Fang, Jiayu; Lv, Minchao; Yang, Min; Deng, Zhouming; Xie, Yuanlong; Cai, Lin

Yang, Zhiqiang; Xie, Jiangtao; Fang, Jiayu; Lv, Minchao; Yang, Min; Deng, Zhouming; Xie, Yuanlong; Cai, Lin.

Affiliation

Yang Z; The Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University, China. Electronic address: yzq2018@whu.edu.cn.
Xie J; The Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University, China.
Fang J; Department of Otorhinolaryngology-Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430000, China.
Lv M; The Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University, China.
Yang M; The Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University, China.
Deng Z; The Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University, China.
Xie Y; The Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University, China. Electronic address: yuanlongxie@whu.edu.cn.
Cai L; The Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University, China. Electronic address: orthopedics@whu.edu.cn.

Biochem Pharmacol ; 198: 114938, 2022 04.

Article de En | MEDLINE | ID: mdl-35114189

Sujet(s)
Mots clés

Anticancer-effects; Nigericin; Osteosarcoma; SRC/STAT3/BCL-2 signaling pathway

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs osseuses / Ostéosarcome Type d'étude: Prognostic_studies Limites: Animals Langue: En Journal: Biochem Pharmacol Année: 2022 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google